Literature DB >> 6110670

Induction of tyrosine aminotransferase in H-35 hepatoma cells by cAMP captured in phospholipid vesicles.

J A Culpepper, A Y Liu.   

Abstract

The uptake, metabolism, and action of cAMP, captured within phospholipid vesicles, in H-35 hepatoma cells were studied. Sonication of lipids in buffer containing cAMP resulted in the formation of 300-A unilamellar lipid vesicles, capturing cAMP in the internal aqueous cavity. Incubation of H-35 hepatoma cells with vesicles containing cAMP (vesicle-cAMP) resulted in rapid incorporation of the vesicle content; apparent saturation of uptake was reached after approximately 30 min of incubation at 37 degrees C. Uptake of vesicle-cAMP was linear over a 10-fold vesicle concentration range. Pretreatment of cells with combined inhibitors of glycolysis and respiration inhibited vesicle uptake by 27%, suggesting vesicle fusion with the cell membrane as a predominant pathway of vesicle uptake. Studies on the metabolism of incorporated cAMP indicated that greater than 50% of the cell-associated radioactivity, derived from vesicle-[3H]cAMP, was preserved as cAMP at the end of a 20-min incubation at 37 degrees C. The incorporation of vesicle-cAMP by H-35 hepatoma cells resulted in increased tyrosine aminotransferase (TAT) activity. The concentration of vesicle-cAMP needed to produce a half-maximal increase in TAT activity was 10 microM, approximately two orders of magnitude lower than that of exogenously added dbcAMP. cAMP was ineffective when added extracellularly. The kinetic relationship of the cAMP-induced increase in TAT activity and the binding of cAMP to its receptor protein, in intact H-35 cells, was examined using vesicle-trapped 8-N3-cAMP, a photoaffinity labeling analogue of cAMP. Incubation of H-35 hepatoma cells with vesicle-8-N3-cAMP resulted in increased TAT activity, preceded by the binding of 8-N3-cAMP to the regulatory subunit of type II cAMP-dependent protein kinase. The use of lipid vesicles provides a means of modulating intracellular cAMP concentration without adding cyclic nucleotide in the millimolar concentration range to the extracellular medium. The increased efficiency of intracellular delivery of cyclic nucleotide with retention of biological activity, provides a useful technique in examining the relationship of occupancy of specific cAMP-receptor protein(s) and the occurrence of a cAMP-mediated biological response in intact cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6110670      PMCID: PMC2111717          DOI: 10.1083/jcb.88.1.89

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  28 in total

1.  Possible role of adenosine cyclic 3':5'-monophosphate phosphodiesterase in the morphological transformation of Chinese hamster ovary cells mediated by N6,O2-dibutyryl adenosine cyclic 3':5"-monophosphate.

Authors:  A W Hsle; K Kawashima; J P O'Neill; C H Schröder
Journal:  J Biol Chem       Date:  1975-02-10       Impact factor: 5.157

2.  Divergent action of cAMP and dibutyryl cAMP on macromolecular synthesis in HeLa S3 cultures.

Authors:  E Kaukel; U Fuhrmann; H Hilz
Journal:  Biochem Biophys Res Commun       Date:  1972-09-26       Impact factor: 3.575

3.  Chemical synthesis and biological activity of 8-substituted adenosine 3',5'-cyclic monophosphate derivatives.

Authors:  K Muneyama; R J Bauer; D A Shuman; R K Robins; L N Simon
Journal:  Biochemistry       Date:  1971-06-08       Impact factor: 3.162

4.  Cyclic nucleotide-dependent protein kinases. IV. Widespread occurrence of adenosine 3',5'-monophosphate-dependent protein kinase in various tissues and phyla of the animal kingdom.

Authors:  J F Kuo; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1969-12       Impact factor: 11.205

5.  Induction of hepatic enzyme synthesis in vivo by adenosine 3', 5'-monophosphate.

Authors:  W D Wicks; F T Kenney; K L Lee
Journal:  J Biol Chem       Date:  1969-11-10       Impact factor: 5.157

6.  A translational control mechanism in mammalian protein synthesis modulated by cyclic adenosine monophosphate. Translational control of tyrosine aminotransferase synthesis in neonatal rat liver.

Authors:  C Chong-Cheng; I T Oliver
Journal:  Biochemistry       Date:  1972-06-20       Impact factor: 3.162

7.  Induction of hepatic enzymes by adenosine 3',5'-monophosphate in organ culture.

Authors:  W D Wicks
Journal:  J Biol Chem       Date:  1969-07-25       Impact factor: 5.157

8.  Studies on phosphatidylcholine vesicles. Formation and physical characteristics.

Authors:  C Huang
Journal:  Biochemistry       Date:  1969-01       Impact factor: 3.162

9.  Induction of hepatic tyrosine aminotransferase in vivo by derivatives of cyclic adenosine 3':5'-monophosphate.

Authors:  J P Miller; A H Beck; L N Simon; R B Meyer
Journal:  J Biol Chem       Date:  1975-01-25       Impact factor: 5.157

10.  Regulation of phosphoenolpyruvate carboxykinase and tyrosine transaminase in hepatoma cell cultures. 3. Comparative studies in H35, HTC, MH1C1 and RLC cells.

Authors:  H van Rijn; M M Bevers; R van Wijk; W D Wicks
Journal:  J Cell Biol       Date:  1974-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.